2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a
Small moleculeexperimental
2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH) is a photosensitiser chemical that is used in photodynamic therapy. — Wikipedia
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 3, 2015 (NCT03757754)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03757754 | Phase 1 | Jun 3, 2015 | People's Liberation Army of China, Zhejiang Hisun Pharmaceutical Co. Ltd. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| People's Liberation Army of China | Government | 1 | 0 | 1 | 2015 |
| Zhejiang Hisun Pharmaceutical Co. Ltd. | For profit | 1 | 1 | 1 | 2015 |
2 organizations
Page 1 / 1